☆ 4.6 Letter

Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Journal

CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Volume 58, Issue 10, Pages E189-E191

Publisher

WALTER DE GRUYTER GMBH

DOI: 10.1515/cclm-2020-0880

Keywords

-

Categories

Medical Laboratory Technology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Virology

Comparison of SARS-CoV-2 serological tests with different antigen targets

Alix T. Coste, Katia Jaton, Matthaios Papadimitriou-Olivgeris, Gilbert Greub, Antony Croxatto

Summary: This study compared 17 SARS-CoV-2 serological tests and found that most tests exhibited high sensitivity and specificity for detecting IgG/pan-Ig in moderately to critically ill hospitalized patients, but had insufficient performance for IgM and IgA detection.

JOURNAL OF CLINICAL VIROLOGY (2021)

Add to Collection

Article Microbiology

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories

Lene H. Harritshoj, Mikkel Gybel-Brask, Shoaib Afzal, Pia R. Kamstrup, Charlotte S. Jorgensen, Marianne Kragh Thomsen, Linda Hilsted, Lennart Friis-Hansen, Pal B. Szecsi, Lise Pedersen, Lene Nielsen, Cecilie B. Hansen, Peter Garred, Trine-Line Korsholm, Susan Mikkelsen, Kirstine O. Nielsen, Bjarne K. Moller, Anne T. Hansen, Kasper K. Iversen, Pernille B. Nielsen, Rasmus B. Hasselbalch, Kamille Fogh, Jakob B. Norsk, Jonas Henrik Kristensen, Kristian Schonning, Nikolai S. Kirkby, Alex C. Y. Nielsen, Lone H. Landsy, Mette Loftager, Dorte K. Holm, Anna C. Nilsson, Susanne G. Saekmose, Birgitte Grum-Schwensen, Bitten Aagaard, Thoger G. Jensen, Dorte M. Nielsen, Henrik Ullum, Ram B. Dessau

Summary: This study evaluated the diagnostic accuracy of 15 commercial and one in-house anti-SARS-CoV-2 assays in Danish laboratories. Most total antibody and IgG assays showed high sensitivity and specificity, with some overlap in confidence intervals. IgM results were more variable, with one assay demonstrating higher sensitivity and specificity.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Serological Tests in the Detection of SARS-CoV-2 Antibodies

Kissy Guevara-Hoyer, Jesus Fuentes-Antras, Eduardo De la Fuente-Munoz, Antonia Rodriguez de la Pena, Marcos Vinuela, Noemi Cabello-Clotet, Vicente Estrada, Esther Culebras, Alberto Delgado-Iribarren, Mercedes Martinez-Novillo, Maria Jose Torrejon, Rebeca Perez de Diego, Miguel Fernandez-Arquero, Alberto Ocana, Pedro Perez-Segura, Silvia Sanchez-Ramon

Summary: Early detection of SARS-CoV-2 through serological testing is crucial for timely management of the virus. Different serological assays have varying levels of sensitivity and specificity, with implications for healthcare organization and treatment strategies.

DIAGNOSTICS (2021)

Add to Collection

Article Multidisciplinary Sciences

Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests

Masashi Nishimura, Satoshi Sugawa, Shinichiro Ota, Etsuko Suematsu, Masahiro Shinoda, Masaharu Shinkai

Summary: Silent infection is estimated to be 6.0% overall and 21.1% among healthcare workers in the COVID-19 ward. Periodical screening with IgG (RBD) in addition to PCR can effectively detect ongoing infection, while IgG (N)(0.2) may be the most reliable indicator for the surveillance of morbidity in the population.

PLOS ONE (2022)

Add to Collection

Article Virology

Evaluation of sixteen ELISA SARS-CoV-2 serological tests

Damien Jacot, Milo Moraz, Alix T. Coste, Christele Aubry, Jilian A. Sacks, Gilbert Greub, Antony Croxatto

Summary: This study evaluated the performance of 16 serological tests for SARS-CoV-2, finding 13 tests with over 90% sensitivity at 15 days post-symptom onset and 97% specificity. No systematic cross-reactivity was observed, but heterogeneities across tests were found.

JOURNAL OF CLINICAL VIROLOGY (2021)

Add to Collection

Review Chemistry, Analytical

Technical considerations to development of serological tests for SARS-CoV-2

Emilie Ernst, Patricia Wolfe, Corrine Stahura, Katie A. Edwards

Summary: The COVID-19 pandemic has led to increased focus on clinical assays, particularly serological testing, to assess exposure to SARS-CoV-2 and immune response to the virus and vaccines. While some tests faced quality issues, they still contribute to public health efforts, highlighting challenges for both emerging technologies and established platforms.

TALANTA (2021)

Add to Collection

Review Immunology

Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection

Kimia Sobhani, Susan Cheng, Raquel A. Binder, Nicholas J. Mantis, James M. Crawford, Nkemakonam Okoye, Jonathan G. Braun, Sandy Joung, Minhao Wang, Gerard Lozanski, Christopher L. King, John D. Roback, Douglas A. Granger, Suresh B. Boppana, Amy B. Karger, Ralph A. Tripp

Summary: In this article, the established clinical use cases for SARS-CoV-2 antibody measures are reviewed, and the definition of an antibody correlate of protection (CoP) for SARS-CoV-2 is examined. The use of binding antibody tests and neutralization tests, as well as the considerations of antibody responses in different populations, vaccine types, and variants, are discussed. The importance of cellular immunity in the nature and durability of protection is also addressed.

VACCINES (2023)

Add to Collection

Article Medical Laboratory Technology

The total testing process harmonization: the case study of SARS-CoV-2 serological tests

Colombini Alessandra, Divieto Carla, Tomaiuolo Rossella, Mortati Leonardo, Jessica Petiti, Di Resta Chiara, Giuseppe Banfi

Summary: Total testing process harmonization is essential for the effectiveness of laboratory medicine. This opinion paper examines the five phases of the TTP and summarizes the critical issues that arise in each phase, using SARS-CoV-2 serological tests as examples. Testing and screening of the population are crucial for defining seropositivity and guiding public health policies in managing the COVID-19 pandemic. However, differences in terminology, measurement units, reference ranges, and result interpretation parameters hinder comparability of analytical results, leading to general confusion. Through interdisciplinary work, the authors propose solutions to achieve effective total testing process harmonization, positively impacting the diagnostic effectiveness of laboratory tests.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Immunology

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays

Maria Infantino, Massimo Pieri, Marzia Nuccetelli, Valentina Grossi, Barbara Lari, Flaminia Tomassetti, Graziella Calugi, Silvia Pancani, Maurizio Benucci, Patrizia Casprini, Mariangela Manfredi, Sergio Bernardini

Summary: The study found that results of different commercial quantitative anti-SARS-CoV-2 assays are not interchangeable, emphasizing the importance of using the same method for individual immune monitoring. Additionally, values expressed as BAU/ml showed reduced between-assays variability compared to values expressed as AU/ml.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Microbiology

Serological Markers of SARS-CoV-2 Reinfection

Sameed M. Siddiqui, Kathryn A. Bowman, Alex L. Zhu, Stephanie Fischinger, Samuel Beger, Jenny S. Maron, Yannic C. Bartsch, Caroline Atyeo, Matthew J. Gorman, Ahmad Yanis, Judd F. Hultquist, Ramon Lorenzo-Redondo, Egon A. Ozer, Lacy M. Simons, Rana Talj, Danielle A. Rankin, Lindsay Chapman, Kyle Meade, Jordan Steinhart, Sean Mullane, Suzanne Siebert, Hendrik Streeck, Pardis Sabeti, Natasha Halasa, Elon R. Musk, Dan H. Barouch, Anil S. Menon, Eric J. Nilles, Douglas A. Lauffenburger, Galit Alter

Summary: As public health guidelines have relaxed, SARS-CoV-2 is likely to remain endemic due to the rise of more infectious variants. Reexposure and reinfection cases have been observed globally, highlighting the need for detecting and monitoring reinfection to prevent vaccine escape mutations. This study identifies simple immune biomarkers of reinfection in rhesus macaques and demonstrates their potential utility in human reinfection cases, providing a cost-effective and scalable marker for targeted pandemic response.

MBIO (2022)

Add to Collection

Article Microbiology

Serological Markers of SARS-CoV-2 Reinfection

Sameed M. Siddiqui, Kathryn A. Bowman, Alex L. Zhu, Stephanie Fischinger, Samuel Beger, Jenny S. Maron, Yannic C. Bartsch, Caroline Atyeo, Matthew J. Gorman, Ahmad Yanis, Judd F. Hultquist, Ramon Lorenzo-Redondo, Egon A. Ozer, Lacy M. Simons, Rana Talj, Danielle A. Rankin, Lindsay Chapman, Kyle Meade, Jordan Steinhart, Sean Mullane, Suzanne Siebert, Hendrik Streeck, Pardis Sabeti, Natasha Halasa, Elon R. Musk, Dan H. Barouch, Anil S. Menon, Eric J. Nilles, Douglas A. Lauffenburger, Galit Alter

Summary: This study emphasizes the importance of detecting SARS-CoV-2 reinfection and suggests that simple antibody titers and function can serve as markers of reinfection, providing increased resolution and resilience against new outbreaks.

MBIO (2022)

Add to Collection

Article Medicine, General & Internal

Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use

Maren Werner, Philip Pervan, Vivian Glueck, Florian Zeman, Michael Koller, Ralph Burkhardt, Thomas Glueck, Juergen J. Wenzel, Barbara Schmidt, Andre Gessner, David Peterhoff

Summary: Serological testing is important for detecting previous infection and monitoring immunity. This study evaluated 16 ELISA/ECLIA and 16 LFA tests using 161 sera samples. Specificities of ELISA/ECLIA tests were acceptable, but sensitivities were lower; LFAs were less accurate than ELISAs. A combination of nucleocapsid and spike protein-based tests is recommended for maximal sensitivity.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Microbiology

Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays

Wayne Dimech, Shannon Curley, Lorenzo Subissi, Ute Stroher, Mark D. D. Perkins, Jane Cunningham

Summary: The markets are flooded with various SARS-CoV-2 serology tests, but there are limited comparative reports on their performance. This study compared 35 rapid diagnostic tests and enzyme immunoassays using samples from individuals with mild to moderate COVID-19 and other coronavirus infections. The results show that independent comparative assessments are important for selecting appropriate test kits, especially during a pandemic.

MICROBIOLOGY SPECTRUM (2023)

Add to Collection

Article Immunology

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases

Nastya Kharlamova, Nicky Dunn, Sahl K. Bedri, Svante Jerling, Malin Almgren, Francesca Faustini, Iva Gunnarsson, Johan Ronnelid, Rille Pullerits, Inger Gjertsson, Karin Lundberg, Anna Manberg, Elisa Pin, Peter Nilsson, Sophia Hober, Katharina Fink, Anna Fogdell-Hahn

Summary: Commercial serological assays for SARS-CoV-2 have poor specificity in patients with chronic inflammatory diseases, leading to a high risk of false positive results, especially among rheumatoid arthritis patients with rheumatoid factor. Therefore, the possibility of false positivity should be considered when interpreting the results of these tests.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Microbiology

Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Serological Diagnostic Tests and Antibody Kinetics in Coronavirus Disease 2019 Patients

Hyun-Woo Choi, Chae-Hyeon Jeon, Eun Jeong Won, Seung-Ji Kang, Seung Yeob Lee, Seung-Jung Kee

Summary: This study evaluated the performance of six serological assays for coronavirus disease 2019 (COVID-19) and found that chemiluminescence assays (CLIAs) and lateral flow immunoassays (LFIAs) had high diagnostic sensitivity and specificity. The positivity rate increased over time in both symptomatic and asymptomatic groups. Trace bands in LFIAs influenced test results. There was a strong positive correlation between binding antibody assays and a surrogate virus neutralization test (sVNT). More objective interpretable assays and the use of sVNT are recommended.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Medical Laboratory Technology

Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots

Luisa Galla, Chiara Cosma, Michela Bertan, Sara Altinier, Martina Zaninotto, Daniela Basso, Alberto Burlina, Andrea Padoan, Mario Plebani

Summary: This study evaluated the prevalence of SARS-CoV-2 IgG antibodies in dried blood spot (DBS) samples in the Trentino region of Italy. The results showed that DBS is a suitable tool for monitoring the COVID-19 pandemic, especially in newborns and pregnant women. The positivity thresholds in DBS increased according to the epidemiological waves of the pandemic.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Medical Laboratory Technology

New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance

Ada Aita, Filippo Navaglia, Stefania Moz, Nicole Contran, Francesco Barbaro, Anna Maria Cattelan, Andrea Padoan, Chiara Cosma, Diego Faggian, Mario Plebani, Daniela Basso

Summary: This study confirmed the effectiveness of CLEIA SARS-CoV-2 salivary antigen detection as an alternative to molecular testing, providing accurate, timely, and high-throughput results. Heat treatment had minimal impact on the detection, ensuring a safer work environment.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Letter Medical Laboratory Technology

Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays

Giuseppe Lippi, Brandon M. Henry, Mario Plebani

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Review Medical Laboratory Technology

Clinical Chemistry and Laboratory Medicine celebrates 60 years - narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2

Julien Favresse, Jonathan Douxfils, Brandon Henry, Giuseppe Lippi, Mario Plebani

Summary: This review highlights the contribution of the journal Clinical Chemistry and Laboratory Medicine (CCLM) in generating knowledge in SARS-CoV-2 diagnosis, with a special focus on COVID-19 research. It emphasizes the importance of the journal in publishing major guidelines related to COVID-19 and its dedication to helping the field better understand and diagnose this emerging disease.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Letter Medical Laboratory Technology

Pre-analytical variability of the Lumipulse immunoassay for plasma biomarkers of Alzheimer's disease

Giulia Musso, Chiara Cosma, Martina Zaninotto, Carlo Gabelli, Daniela Basso, Mario Plebani

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Medical Laboratory Technology

An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs)

Giuseppe Lippi, Brandon M. Henry, Mario Plebani

Summary: Due to technical limitations, the diagnostic testing for SARS-CoV-2 mainly relies on antigen rapid diagnostic tests (Ag-RDTs). However, these tests have limited analytical sensitivity and require manual operation, often performed by unskilled personnel or patients themselves, which may significantly impair their accuracy. This article provides an updated overview of the preanalytical drawbacks that may affect the accuracy of SARS-CoV-2 Ag-RDTs.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Letter Medical Laboratory Technology

Response to Tony Badrick regarding Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2): 205-212 by

Wayne J. Dimech, Giuseppe A. Vincini, Mario Plebani, Giuseppe Lippi, James H. Nichols, Oswald Sonntag

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Review Medical Laboratory Technology

Why C-reactive protein is one of the most requested tests in clinical laboratories?

Mario Plebani

Summary: C-reactive protein (CRP) is a sensitive systemic marker of inflammation and tissue damage, synthesized by the liver in response to inflammatory cytokines. It is widely used for the diagnosis and monitoring of inflammatory conditions. The advances in analytical methods and automation have increased the demand for CRP measurement in systemic inflammatory diseases and atherothrombotic events, and it has recently gained interest as a biomarker for the severity of COVID-19, requiring further study for improved interpretation of results.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Editorial Material Medical Laboratory Technology

ChatGPT: Angel or Demond? Critical thinking is still needed

Mario Plebani

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Medical Laboratory Technology

Striving for a pragmatic contribution of biomarkers results to lifelong health care

Simona Ferraro, Cristina Cereda, Gianvincenzo Zuccotti, Santica Marcovina, Mario Plebani, Elia Mario Biganzoli

Summary: The aim of this paper is to explore the practical application of laboratory results in the decision-making process for improving healthcare outcomes, through the collaboration between laboratory professionals and experts in econometric, bioinformatics, and biostatistics. The content focuses on the effectiveness of biomarkers, analytical challenges, lack of result harmonization, and factors limiting healthcare effectiveness in clinical chemistry and newborn screening tests.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Medical Laboratory Technology

Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay

Laura Pighi, Brandon M. Henry, Simone De Nitto, Gianluca Gianfilippi, Gian Luca Salvagno, Mario Plebani, Giuseppe Lippi

Summary: In this study, the clinical performance of the SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay (MAG-CLIA SARS-CoV-2 Ag) was reported. The results showed satisfactory analytical performance of MAG-CLIA SARS-CoV-2 Ag, which could be used as a surrogate for molecular testing in identifying high viral load samples.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Medical Laboratory Technology

Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples

Andrea Padoan, Ilaria Talli, Chiara Cosma, Stefania Moz, Giulia Furlan, Filippo Navaglia, Lucio Marchioro, Martina Zaninotto, Daniela Basso, Mario Plebani

Summary: This study describes the analytical and clinical performances of the SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay (MAG-CLIA) on salivary samples. The results show satisfactory analytical performance of MAG-CLIA and high specificity in salivary samples.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Article Medical Laboratory Technology

Machine learning-based nonlinear regression-adjusted real-time quality control modeling: a multi-center study

Yu-fang Liang, Andrea Padoan, Zhe Wang, Chao Chen, Qing-tao Wang, Mario Plebani, Rui Zhou

Summary: The study aims to develop a machine learning-based patient-based real-time quality control method, which can effectively detect errors in different datasets and has wide application value.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Review Medical Laboratory Technology

Rising adoption of artificial intelligence in scientific publishing: evaluating the role, risks, and ethical implications in paper drafting and review process

Anna Carobene, Andrea Padoan, Federico Cabitza, Giuseppe Banfi, Mario Plebani

Summary: The use of artificial intelligence in scientific publishing offers great potential but also raises significant ethical and operational challenges. Recognizing the importance of human reviewers is crucial to maintain authenticity in an AI-influenced environment.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.